Skip to main content

Table 2 Mammaglobin A and lipophilin B (co)expression data from cDNA dot blots

From: Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies

  

Mammaglobin A regulation *

Lipophilin B regulation *

Concordance of expression

Tissue type

n (total)

up

down-

no

up-

down-

no

 
  

n

%

n

%

n

%

n

%

n

%

n

%

 

Breast

59

7

12%

29

49%

23

39%

2

3%

35

59%

22

38%

Yes (78%)

Uterus

49

23

47%

11

22%

15

31%

24

49%

11

22%

14

29%

Yes (78%)

Ovary

18

5

28%

3

17%

10

55%

4

22%

6

33%

8

45%

Yes (56%)

Cervix

2

2

100%

0

0%

0

0%

2

100%

0

0%

0

0%

Yes (100%)

Kidney

34

1

3%

0

0%

0

0%

1

3%

16

47%

17

50%

No

Prostate

7

n.e.

n.e.

n.e.

0

0%

2

29%

5

71%

No

  1. n.e.: not expressed
  2. * The percentage of up-regulation (or down-regulation) was defined as follows: The number of tumor/normal tissue pairs with an at least 2-fold-up-regulation (or down-regulation) in the tumor tissue divided by the total number of samples in this entity × 100. Fold changes between 0.5 and 2.0 were considered as not differentially expressed ("no regulation").